The 2018 National Institute on Aging–Alzheimer's Association (NIA‐AA) research framework defines AD biologically, based on three core pathological processes: amyloid deposition (A), tau pathology (T), and neurodegeneration (N) (ATN) (Jack Jr. The gene discussed is MAPT; the disease is Alzheimer disease.